AAAAAA

   
Results: 1-10 |
Results: 10
HUMAN-LYMPHOCYTES PRODUCE UROCORTIN, BUT NOT CORTICOTROPIN-RELEASING HORMONE
Authors: BAMBERGER CM WALD M BAMBERGER AM ERGUN S BEIL FU SCHULTE HM
Citation: Cm. Bamberger et al., HUMAN-LYMPHOCYTES PRODUCE UROCORTIN, BUT NOT CORTICOTROPIN-RELEASING HORMONE, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 708-711
RATIONAL OF LIPID THERAPY - PREVENTION OR TREATMENT OF CORONARY HEART-DISEASE
Authors: WINDLER E BEIL FU
Citation: E. Windler et Fu. Beil, RATIONAL OF LIPID THERAPY - PREVENTION OR TREATMENT OF CORONARY HEART-DISEASE, Herz, 22(3), 1997, pp. 125-133
GOALS AND PROCEDURE OF LIPID INTERVENTION IN CORONARY HEART-DISEASE
Authors: BEIL FU WINDLER E
Citation: Fu. Beil et E. Windler, GOALS AND PROCEDURE OF LIPID INTERVENTION IN CORONARY HEART-DISEASE, Herz, 22(3), 1997, pp. 134-140
REGULATION OF THE HUMAN INTERLEUKIN-2 GENE BY THE ALPHA-ISOFORM AND BETA-ISOFORM OF THE GLUCOCORTICOID RECEPTOR
Authors: BAMBERGER CM ELSE T BAMBERGER AM BEIL FU SCHULTE HM
Citation: Cm. Bamberger et al., REGULATION OF THE HUMAN INTERLEUKIN-2 GENE BY THE ALPHA-ISOFORM AND BETA-ISOFORM OF THE GLUCOCORTICOID RECEPTOR, Molecular and cellular endocrinology, 136(1), 1997, pp. 23-28
ACUTE EFFECTS OF HEPARIN ON TRIGLYCERIDE, APOLIPOPROTEIN-E AND LIPOPROTEIN-LIPASE LEVELS IN HUMANS
Authors: MANN WA BRUMMER D EVANS D BERG D BERGMANN J BEIL FU BEISIEGEL U
Citation: Wa. Mann et al., ACUTE EFFECTS OF HEPARIN ON TRIGLYCERIDE, APOLIPOPROTEIN-E AND LIPOPROTEIN-LIPASE LEVELS IN HUMANS, Atherosclerosis, 130, 1997, pp. 52-52
HIGH-LEVEL RECOMBINANT EXPRESSION AND SUBSTRATE-SPECIFICITY OF LYSOSOMAL ACID LIPASE
Authors: AMEIS D TILKORN AC MERKEL M GEORGE E BEIL FU GRETEN H
Citation: D. Ameis et al., HIGH-LEVEL RECOMBINANT EXPRESSION AND SUBSTRATE-SPECIFICITY OF LYSOSOMAL ACID LIPASE, Circulation, 94(8), 1996, pp. 2718-2718
RAPID ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE IN PATIENTSWITH ELEVATED LIPOPROTEIN(A)
Authors: TERRES W TATSIS E PFALZER B BEIL FU BEISIEGEL U HAMM CW
Citation: W. Terres et al., RAPID ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE IN PATIENTSWITH ELEVATED LIPOPROTEIN(A), Thrombosis and haemostasis, 73(6), 1995, pp. 1394-1394
RAPID ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE IN PATIENTSWITH ELEVATED LIPOPROTEIN(A)
Authors: TERRES W TATSIS E PFALZER B BEIL FU BEISIEGEL U HAMM CW
Citation: W. Terres et al., RAPID ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE IN PATIENTSWITH ELEVATED LIPOPROTEIN(A), Circulation, 91(4), 1995, pp. 948-950
TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA - FLUVASTATIN VERSUS BEZAFIBRATE
Authors: GRETEN H BEIL FU SCHNEIDER J WEISWEILER P ARMSTRONG VW KELLER C KLOR HU VONHODENBERG E WEIDINGER G ESKOTTER H FARBER L ASSMANN G
Citation: H. Greten et al., TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA - FLUVASTATIN VERSUS BEZAFIBRATE, The American journal of medicine, 96, 1994, pp. 190000055-190000063
CHYLOMICRONEMIA SYNDROME DUE TO APOPROTEI N-CII DEFICIENCY
Authors: BEIL FU
Citation: Fu. Beil, CHYLOMICRONEMIA SYNDROME DUE TO APOPROTEI N-CII DEFICIENCY, Die medizinische Welt, 44(12), 1993, pp. 733-738
Risultati: 1-10 |